慢性丙型肝炎肝纤维化的无创评估。
Non-invasive assessment of liver fibrosis in chronic hepatitis C.
机构信息
Service d'Hépatologie, Hôpital Beaujon, AP-HP, Université Denis Diderot Paris-VII, Clichy, France,
出版信息
Hepatol Int. 2011 Jun;5(2):625-34. doi: 10.1007/s12072-010-9240-0. Epub 2011 Jan 20.
Abstract
Quantification of hepatic fibrosis is of critical importance in chronic hepatitis C not only for prognosis, but also for antiviral treatment indication. Two end points are clinically relevant: detection of significant fibrosis (indication for antiviral treatment) and detection of cirrhosis (screening for eosphageal varices and hepatocellular carcinoma). Until recently, liver biopsy was considered the reference method for the evaluation of liver fibrosis. Limitations of liver biopsy (invasiveness, sampling error, and inter-observer variability) have led to the development of non-invasive methods. Currently available methods rely on two different approaches: a "biological" approach based on the dosage of serum fibrosis biomarkers; and a "physical" approach based on the measurement of liver stiffness, using transient elastography (TE). This review is aimed at discussing the advantages and limits of non-invasive methods and liver biopsy and the perspectives for their rational use in clinical practice in the management of patients with chronic hepatitis C.
摘要
肝纤维化的定量评估对慢性丙型肝炎至关重要，不仅对预后有影响，而且对抗病毒治疗的适应证也有影响。有两个临床相关的终点：检测显著的纤维化（抗病毒治疗的适应证）和检测肝硬化（筛查食管静脉曲张和肝细胞癌）。直到最近，肝活检一直被认为是评估肝纤维化的参考方法。肝活检的局限性（侵袭性、取样误差和观察者间的变异性）导致了非侵入性方法的发展。目前可用的方法依赖于两种不同的方法：一种是基于血清纤维化生物标志物剂量的“生物学”方法；另一种是基于使用瞬时弹性成像（TE）测量肝硬度的“物理”方法。这篇综述旨在讨论非侵入性方法和肝活检的优缺点以及在慢性丙型肝炎患者管理中合理使用这些方法的前景。
相似文献
1
Non-invasive assessment of liver fibrosis in chronic hepatitis C.慢性丙型肝炎肝纤维化的无创评估。
Hepatol Int. 2011 Jun;5(2):625-34. doi: 10.1007/s12072-010-9240-0. Epub 2011 Jan 20.
2
Noninvasive Assessment of Liver Fibrosis.肝纤维化的无创评估
Dig Dis. 2015;33(4):498-503. doi: 10.1159/000374097. Epub 2015 Jul 6.
3
How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?如何评估慢性丙型肝炎肝纤维化：血清标志物还是瞬时弹性成像与肝活检？
Liver Int. 2011 Jan;31 Suppl 1:13-7. doi: 10.1111/j.1478-3231.2010.02380.x.
4
Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.用于肝脏疾病的超声剪切波弹性成像：对该领域众多参与者的批判性评估
Ultraschall Med. 2016 Feb;37(1):1-5. doi: 10.1055/s-0035-1567037. Epub 2016 Feb 12.
5
Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.用于评估慢性肝病纤维化和疾病进展的侵入性和非侵入性方法。
Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):291-303. doi: 10.1016/j.bpg.2011.02.003.
6
Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.瞬时弹性成像在接受抗病毒治疗的慢性病毒性肝炎患者中的临床应用。
Liver Int. 2015 Apr;35(4):1103-15. doi: 10.1111/liv.12628. Epub 2014 Jul 19.
7
Non-invasive assessment of liver fibrosis in chronic hepatitis B.慢性乙型肝炎中肝纤维化的无创评估
World J Gastroenterol. 2014 Oct 28;20(40):14568-80. doi: 10.3748/wjg.v20.i40.14568.
8
Limitations of non-invasive tests for assessment of liver fibrosis.用于评估肝纤维化的非侵入性检测的局限性。
JHEP Rep. 2020 Jan 20;2(2):100067. doi: 10.1016/j.jhepr.2020.100067. eCollection 2020 Apr.
9
[Non-invasive diagnostic methods of fibrosis in chronic hepatitis C virus infection: their role in treatment indication, follow-up and assessment of prognosis].[丙型肝炎病毒慢性感染中纤维化的非侵入性诊断方法：其在治疗指征、随访及预后评估中的作用]
Orv Hetil. 2015 May 24;156(21):855-61. doi: 10.1556/650.2015.30173.
10
Assessing liver fibrosis.评估肝纤维化。
Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):541-52. doi: 10.1586/17474124.2.4.541.
引用本文的文献
1
Non-Invasive versus Invasive Assessment of Portal Hypertension in Chronic Liver Disease.慢性肝病门静脉高压的非侵入性与侵入性评估
GE Port J Gastroenterol. 2024 Apr 22;31(6):377-387. doi: 10.1159/000538484. eCollection 2024 Dec.
2
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents.增强型肝纤维化评分作为直接作用抗病毒药物治疗后丙型肝炎病毒患者的一种非侵入性生物标志物。
Front Pharmacol. 2022 Aug 17;13:891398. doi: 10.3389/fphar.2022.891398. eCollection 2022.
3
Comparison of superb microvascular imaging and shear wave elastography for assessing liver fibrosis in chronic hepatitis B.超微血管成像与剪切波弹性成像在评估慢性乙型肝炎肝纤维化中的比较
Ultrasonography. 2022 Apr;41(2):394-402. doi: 10.14366/usg.21136. Epub 2021 Nov 25.
4
Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study.糖尿病对慢性丙型肝炎病毒学治愈和未治愈患者肝硬度的影响：一项纵向研究。
Clinics (Sao Paulo). 2021 Nov 8;76:e3236. doi: 10.6061/clinics/2021/e3236. eCollection 2021.
5
Evaluation of liver fibrosis using hepatic extracellular volume fraction by contrast-enhanced computed tomography before and after direct-acting antiviral therapy in patients with chronic hepatitis C infection: comparison with serological liver fibrosis markers.应用对比增强 CT 测量肝外细胞体积分数评估慢性丙型肝炎感染患者直接抗病毒治疗前后的肝纤维化：与血清学肝纤维化标志物的比较。
Br J Radiol. 2021 Nov 1;94(1127):20210045. doi: 10.1259/bjr.20210045. Epub 2021 Sep 29.
6
Exploring Interactions between Primary Hepatocytes and Non-Parenchymal Cells on Physiological and Pathological Liver Stiffness.探索原代肝细胞与非实质细胞在生理和病理肝脏硬度方面的相互作用。
Biology (Basel). 2021 May 5;10(5):408. doi: 10.3390/biology10050408.
7
Prediction of Cirrhosis in Patients with Chronic Hepatitis C by Genotype 3.基因3型慢性丙型肝炎患者肝硬化的预测
Euroasian J Hepatogastroenterol. 2020 Jan-Jun;10(1):7-10. doi: 10.5005/jp-journals-10018-1311.
8
Substrate stiffness regulates primary hepatocyte functions.底物硬度调节原代肝细胞功能。
RSC Adv. 2015;5(99):80956-80966. doi: 10.1039/C5RA15208A. Epub 2015 Sep 14.
9
Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.新型肝疾病标志物与早产短面猴（Papio sp.）新生儿肝疾病的相关性研究
PLoS One. 2020 Mar 9;15(3):e0228985. doi: 10.1371/journal.pone.0228985. eCollection 2020.
10
Liver Bioreactor Design Issues of Fluid Flow and Zonation, Fibrosis, and Mechanics: A Computational Perspective.肝脏生物反应器的流体流动、分区、纤维化及力学设计问题：计算视角
J Funct Biomater. 2020 Feb 28;11(1):13. doi: 10.3390/jfb11010013.
本文引用的文献
1
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).FibroScan 在慢性病毒性肝炎中的诊断准确性及其与肝纤维化生物标志物的比较：一项多中心前瞻性研究（FIBROSTIC 研究）。
J Hepatol. 2010 Dec;53(6):1013-21. doi: 10.1016/j.jhep.2010.05.035. Epub 2010 Aug 14.
2
Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review.非侵入性检测在肝移植后 HCV 复发纤维化评估中的应用：系统综述。
Transpl Int. 2010 Sep;23(9):861-70. doi: 10.1111/j.1432-2277.2010.01142.x.
3
Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?肝纤维化诊断的活检与非侵入性方法：双人探戈需要两人配合？
Gut. 2010 Jul;59(7):861-6. doi: 10.1136/gut.2010.214650.
4
Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis.声辐射力脉冲：一种新的超声技术，可广泛用于非侵入性诊断肝纤维化。
Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1074-84. doi: 10.1097/MEG.0b013e328339e0a1.
5
Non-invasive assessment of liver fibrosis: are we ready?肝纤维化的非侵入性评估：我们准备好了吗？
Lancet. 2010 Apr 24;375(9724):1419-20. doi: 10.1016/S0140-6736(09)62195-4.
6
Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.肝移植患者通过瞬时弹性成像和非侵入性生物标志物评分系统评估移植物纤维化。
Transplantation. 2010 Apr 27;89(8):983-93. doi: 10.1097/TP.0b013e3181cc66ca.
7
Acoustic radiation force impulse imaging: a new technology for the noninvasive assessment of liver fibrosis?声辐射力脉冲成像：一种用于肝纤维化无创评估的新技术？
J Gastrointestin Liver Dis. 2009 Dec;18(4):411-2.
8
Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations.肝脏硬度测量的陷阱：一项 13369 次检查的 5 年前瞻性研究。
Hepatology. 2010 Mar;51(3):828-35. doi: 10.1002/hep.23425.
9
Liver stiffness is directly influenced by central venous pressure.肝硬度直接受中心静脉压的影响。
J Hepatol. 2010 Feb;52(2):206-10. doi: 10.1016/j.jhep.2009.11.018. Epub 2009 Dec 4.
10
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.两种非侵入性方法联合分期慢性丙型肝炎肝纤维化的前瞻性比较。
J Hepatol. 2010 Feb;52(2):191-8. doi: 10.1016/j.jhep.2009.11.008. Epub 2009 Nov 24.
Zotero 插件